$SNEX

Perkins Abigail H sold $628K of SNEX

Perkins Abigail H (Chief Information Officer) sold 8,919 shares of StoneX Group Inc. (SNEX) at $70.43 ($0.63M total) on 2026-07-20 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Perkins Abigail H
Published Jul 22, 2026, 12:17 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 22, 2026, 12:33 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SNEX
Neutral
high confidence
Mentioned
$SNEX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNEXNeutralLow
01

Why it matters

The disclosed sale is a planned open-market transaction by the CIO, which typically carries limited informational content versus unscheduled sales.

02

Market read

Traders may use the disclosure to gauge insider activity, but it does not provide new fundamentals or guidance.

03

What to watch

The article does not state whether the sale was part of a broader series, whether other insiders sold/bought around the same time, or whether the CIO’s remaining holdings changed materially versus prior plans.

Relevance 4/10Novelty 3/10Timing: Filed after-hours on 2026-07-21 for a sale dated 2026-07-20.

Background

The article is a SEC Form 4 insider transaction report for StoneX Group Inc. (SNEX).

Company-level read

Ticker impact

$SNEXNeutralHigh confidence
Context

StoneX CIO Perkins Abigail H sold 8,919 shares in an open-market transaction for about $628K under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new company-specific operational or financial information.

Market effects

Minimal, as the disclosure is company-specific and does not indicate sector-wide regulatory or business changes.

None indicated.

None indicated.

Counterpoint

Even planned 10b5-1 sales can coincide with insider expectations of near-term risk, so traders may still watch for follow-on selling or other insider activity.

Key entities

  • StoneX Group Inc.

    Company whose insider transaction is disclosed on Form 4.

  • Perkins Abigail H

    Chief Information Officer who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WGOMedAI 8/10

Winnebago stock rises as StoneX lowers price target on industry outlook

StoneX lowered its price target on Winnebago (WGO) to $36 from $40, maintaining a Buy rating. The stock trades at $26.83 with a 5.62% dividend yield. Winnebago issued fiscal 2027 guidance for sales of $2.65B-$2.80B and adjusted EPS of $1.65-$2.25, with midpoints above consensus. The company reduced 2026 RV shipment expectations and guided 2027 shipments to 265,000-295,000 units. The stock rose 10.5% on Monday following earnings and guidance.

$MXLMed

MaxLinear stock rating reiterated at Buy by StoneX ahead of results

StoneX reiterated a Buy rating on MaxLinear (MXL) with a $125 price target ahead of its October 22 earnings report. The firm expects Q3 revenue of $215M-$220M, matching consensus. MXL shares are down 20% in a week but up 320% year-to-date. S&P upgraded its outlook to positive, citing strong infrastructure revenue growth. Analysts highlight MXL's potential in the optical market.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.